Tocagen enrolls first patient in Phase 2/3 clinical trial in patients with recurrent glioblastoma
"The current lack of effective therapies for high grade gliomas, such as glioblastoma and anaplastic astrocytoma, leaves doctors with few options for treating patients," said Tom Mikkelsen, M.D.,